Omnicell Research Development from 2010 to 2026

OMCL Stock  USD 46.04  2.66  5.46%   
Omnicell Research Development yearly trend continues to be quite stable with very little volatility. Research Development may rise above about 109.2 M this year. From the period between 2010 and 2026, Omnicell, Research Development regression line of its data series had standard deviation of  32,423,268 and standard deviation of  32,423,268. View All Fundamentals
 
Research Development  
First Reported
2000-03-31
Previous Quarter
21.6 M
Current Value
24 M
Quarterly Volatility
M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Omnicell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omnicell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 108.4 M, Interest Expense of 3.4 M or Selling General Administrative of 459.2 M, as well as many indicators such as Price To Sales Ratio of 2.02, Dividend Yield of 0.0 or PTB Ratio of 3.78. Omnicell financial statements analysis is a perfect complement when working with Omnicell Valuation or Volatility modules.
  
Build AI portfolio with Omnicell Stock
Check out the analysis of Omnicell Correlation against competitors.
For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.
Historical Research Development data for Omnicell serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Omnicell represents a compelling investment opportunity.

Latest Omnicell's Research Development Growth Pattern

Below is the plot of the Research Development of Omnicell over the last few years. It is Omnicell's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Omnicell's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Omnicell Research Development Regression Statistics

Arithmetic Mean62,231,488
Geometric Mean52,194,186
Coefficient Of Variation52.10
Mean Deviation26,907,460
Median66,022,000
Standard Deviation32,423,268
Sample Variance1051.3T
Range97.9M
R-Value0.98
Mean Square Error55T
R-Squared0.95
Slope6,261,192
Total Sum of Squares16820.3T

Omnicell Research Development History

2026109.2 M
2025104 M
202490.4 M
202397.1 M
2022105 M
202175.7 M
202070.2 M

About Omnicell Financial Statements

Omnicell investors utilize fundamental indicators, such as Research Development, to predict how Omnicell Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development104 M109.2 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Omnicell is a strong investment it is important to analyze Omnicell's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omnicell's future performance. For an informed investment choice regarding Omnicell Stock, refer to the following important reports:
Check out the analysis of Omnicell Correlation against competitors.
For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. Anticipated expansion of Omnicell directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Omnicell assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
(0.36)
Earnings Share
0.43
Revenue Per Share
25.429
Quarterly Revenue Growth
0.1
Return On Assets
0.0054
Understanding Omnicell requires distinguishing between market price and book value, where the latter reflects Omnicell's accounting equity. The concept of intrinsic value - what Omnicell's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Omnicell's price substantially above or below its fundamental value.
It's important to distinguish between Omnicell's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Omnicell should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Omnicell's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.